Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 1;124(17):3500-3509.
doi: 10.1002/cncr.31638. Epub 2018 Sep 6.

Trends in breast cancer mortality by stage at diagnosis among young women in the United States

Affiliations

Trends in breast cancer mortality by stage at diagnosis among young women in the United States

Fangjian Guo et al. Cancer. .

Abstract

Background: Assessing trends in breast cancer survival among young women who are largely unaffected by breast cancer screening will provide important information regarding improvements in the effectiveness of cancer care for breast cancer in the last few decades.

Methods: The cohort for this study consisted of women who were diagnosed with breast cancer between ages 20 and 39 years from the Surveillance, Epidemiology, and End Results program's 9-registry areas from 1975 to 2015. Trends in the breast cancer incidence rate and survival were assessed among young women.

Results: Among women aged 20 to 39 years, breast cancer incidence increased from 24.6 per 100,000 in 1975 to 31.7 per 100,000 in 2015 (annual percent change, 0.5; 95% confidence interval [CI], 0.4-0.6). Among women with breast cancer, 5-year breast-cancer-specific survival increased significantly from 74.0% during 1975 to 1979 to 88.5% during 2010 to 2015 (hazard ratio for dying from breast cancer for 2010-2015 vs 1975-1979, 0.37; 95% CI, 0.32-0.41). The increase in cancer-specific survival reached a plateau in 2005; however, among young women with metastatic breast cancer, it continued to increase after 2005, from 45.6% during 2005 to 2009 to 56.5% during 2010 to 2015 (hazard ratio for dying from breast cancer for 2010-2015 vs 2005-2009, 0.74; 95% CI, 0.60-0.92). Similar patterns also were observed for 5-year overall survival and among women aged 20 to 29 years and those aged 30 to 39 years.

Conclusions: There were substantial improvements in the effectiveness of breast cancer treatment on overall and cancer-specific survival from 1975 to 2015. However, improvements appeared to have reached a plateau after 2005, except among young women with metastatic breast cancer, in whom survival continued to improve throughout the period.

Keywords: breast cancer; ductal carcinoma in situ (DCIS); incidence; survival.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: The authors report no conflict of interest.

Figures

Figure 1
Figure 1
Age-adjusted incidence in breast cancer among women 20–39 years old, SEER 1975–2015. A. All cases and invasive breast cancer. B. DCIS and metastatic cancer. DCIS: ductal carcinoma in situ. All cases: include invasive breast cancer and DCIS.
Figure 1
Figure 1
Age-adjusted incidence in breast cancer among women 20–39 years old, SEER 1975–2015. A. All cases and invasive breast cancer. B. DCIS and metastatic cancer. DCIS: ductal carcinoma in situ. All cases: include invasive breast cancer and DCIS.
Figure 2
Figure 2
Five-year cumulative probability of death from breast cancer among breast cancer patients 20–39 years old, SEER 1975–2015. A: All cases. B. Metastatic breast cancer. DCIS: Ductal carcinoma in situ. All cases: include invasive breast cancer and DCIS. Cumulative percent dying from breast cancer = 1 - cancer-specific survival.
Figure 2
Figure 2
Five-year cumulative probability of death from breast cancer among breast cancer patients 20–39 years old, SEER 1975–2015. A: All cases. B. Metastatic breast cancer. DCIS: Ductal carcinoma in situ. All cases: include invasive breast cancer and DCIS. Cumulative percent dying from breast cancer = 1 - cancer-specific survival.
Figure 3
Figure 3
Age-adjusted incidence in DCIS and metastatic breast cancer among women 20–39 years old by age groups, SEER 1975–2015. DCIS: ductal carcinoma in situ. A. 20–29 years old. B. 30–39 years old. Annual percentage changes (APC) and p values: Among women 20–29 years old DCIS: 1975–2015 APC 2.8 p<0.001 Metastatic: 1975–2015 APC 3.8 p<0.001 Among women 30–39 years old DCIS: 1975–1989 APC 11.1, p<0.001; 1989–2005 APC 2.5, p=0.001; 2005–2015 APC −1.9, p=0.14. 1975–1989 vs. 1989–2005 p<0.001. 1989–2005 vs. 2005–2015 p=0.005) Metastatic: 1975–1995 APC 0.8, p=0.22; 1995–2015 APC 3.9, p<0.001. P value for the difference <0.001
Figure 3
Figure 3
Age-adjusted incidence in DCIS and metastatic breast cancer among women 20–39 years old by age groups, SEER 1975–2015. DCIS: ductal carcinoma in situ. A. 20–29 years old. B. 30–39 years old. Annual percentage changes (APC) and p values: Among women 20–29 years old DCIS: 1975–2015 APC 2.8 p<0.001 Metastatic: 1975–2015 APC 3.8 p<0.001 Among women 30–39 years old DCIS: 1975–1989 APC 11.1, p<0.001; 1989–2005 APC 2.5, p=0.001; 2005–2015 APC −1.9, p=0.14. 1975–1989 vs. 1989–2005 p<0.001. 1989–2005 vs. 2005–2015 p=0.005) Metastatic: 1975–1995 APC 0.8, p=0.22; 1995–2015 APC 3.9, p<0.001. P value for the difference <0.001

References

    1. DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66:31–42. - PubMed
    1. American Cancer Society. Breast Cancer Facts & Figures 2015–2016. Atlanta: American Cancer Society, Inc. 2015. http://www.cancer.org/acs/groups/content/@research/documents/document/ac.... Accessed on June 30,
    1. Welch HG, Prorok PC, O'Malley AJ, Kramer BS. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. N Engl J Med. 2016;375:1438–1447. - PubMed
    1. Liu PH, Wang JD, Keating NL. Expected years of life lost for six potentially preventable cancers in the United States. Prev Med. 2013;56:309–313. - PubMed
    1. U.S. Preventive Services Task Force. The Guide to Clinical Preventive Services, 2014. Available at: http://www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians.... Accessed August 26, 2016.

Publication types